Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 14/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 9/20 | 0.41 |
| ▸ | MEF2D | Q14814 | 5/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 6/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 7/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.41 |
| ▸ | TET3 | O43151 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | FOXO1 | Q12778 | 1/20 | 0.40 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.40 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.40 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32690769 | 0.93 | HDAC1 (0.47) | ARHDAC1HDAC4MEF2DKCNH2 | |
| SCHEMBL32690805 | 0.90 | AR (0.45) | ARHDAC1HDAC3HDAC6 | |
| SCHEMBL32690840 | 0.88 | HDAC1 (0.42) | HDAC1HDAC4MEF2DHDAC2HDAC3 | |
| SCHEMBL32690823 | 0.86 | AR (0.49) | ARHDAC1HDAC3HDAC6HDAC8 | |
| SCHEMBL32690715 | 0.86 | HDAC6 (0.42) | HDAC1HDAC4HDAC2HDAC3HDAC6 | |
| SCHEMBL32690793 | 0.85 | HDAC1 (0.48) | HDAC1HDAC4HDAC2HDAC3HDAC6 | |
| SCHEMBL32690847 | 0.84 | HDAC6 (0.47) | HDAC1HDAC4MEF2DKCNH2HDAC2 | |
| SCHEMBL32690748 | 0.84 | CCNB2 (0.43) | ARHDAC1HDAC2HDAC3HDAC6 | |
| SCHEMBL32690677 | 0.82 | HDAC1 (0.42) | HDAC1HDAC4MEF2DKCNH2HDAC2 | |
| SCHEMBL32690736 | 0.82 | AR (0.48) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085046-A1 | Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition | TAIWANJ PHARMACEUTICALS CO LTD (TW) | 2026-03-26 | — | — | US | claimed |
| US-20260085046-A1 | Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition | TAIWANJ PHARMACEUTICALS CO LTD (TW) | 2026-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085046-A1 | Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition | NOX1, NOX4, CYBB | AR 532/4885HDAC1 7/4885HDAC4 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.